Mitochondria and Necroptosis – New Insights into Human and Experimental Kidney Disease
Dates and Times
Start: 5/19/2021 8:00 AM
End: 5/19/2021 9:00 AM
• Kidney disease is a common and debilitating medical condition affecting about 1 in 7 adults in the U.S. for which there is an unmet need to develop new therapies.
• Gaining an understanding of the mechanism of disease pathogenesis is crucial in developing new therapies.
• Mitochondrial dysfunction and necroptosis have emerged as critical molecular events in kidney disease that may serve as new therapeutic targets.
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.